初次与翻修全膝关节置换术后的静脉血栓栓塞疾病
基于2003—2012年全州规划与研究合作系统数据库的225584例全膝关节置换术(208954例初次、16630例翻修),翻修较初次全膝关节置换术的静脉血栓栓塞症风险更低,30天多变量校正OR为0.81,90天为0.87。该关联在肺栓塞中强于深静脉血栓。
要点
- 翻修全膝关节置换术30天静脉血栓栓塞症发生率为1.84%,初次为2.24%。
- 翻修较初次全膝关节置换术30天静脉血栓栓塞症校正OR为0.81(95%CI 0.72-0.91,P<.001)。
- 90天肺栓塞校正OR为0.69(P<.001),深静脉血栓OR为0.94(P=.284)无显著差异。
核心结论
- 在大型全州数据库中,翻修全膝关节置换术较初次全膝关节置换术的静脉血栓栓塞症风险更低。
- 作者认为该现象原因尚不明确,可能与翻修手术患者接受了更积极的预防性管理有关。
- 作者建议未来研究应尝试阐明初次与翻修手术在患者选择和管理上的差异。
研究设计与样本
- 回顾性数据库研究,纳入2003—2012年全州规划与研究合作系统数据库中225584例全膝关节置换术(208954例初次、16630例翻修)。
- 以比值比(OR)表达翻修相对于初次全膝关节置换术的静脉血栓栓塞症风险,模型校正年龄、性别、种族和Charlson合并症评分。
- 结局分析进一步分层为深静脉血栓(DVT)和肺栓塞(PE)。
主要发现
- 30天静脉血栓栓塞症发生率初次为2.24%、翻修为1.84%;多变量校正后翻修较初次的OR为0.81(95%CI 0.72-0.91,P<.001)。
- 90天静脉血栓栓塞症发生率初次为2.42%、翻修为2.13%(P=.022),多变量校正后翻修较初次的OR为0.87(95%CI 0.78-0.97,P=.010)。
- 30天时肺栓塞的关联(OR=0.63,P<.001)强于深静脉血栓(OR=0.87,P=.035)。
- 90天时肺栓塞的关联显著(OR=0.69,P<.001),但深静脉血栓不显著(OR=0.94,P=.284)。
局限性
- 作者指出该观察的原因尚不明确,可能与翻修手术患者接受了更积极的预防性管理有关。
- 作者建议未来研究应尝试阐明初次与翻修手术在患者选择和管理上的差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Venous thromboembolic disease (VTED) is a serious complication of primary and revision total knee arthroplasty (TKA). However, the incidence and risk of VTED for revision compared with primary TKA cases have not been well-described. METHODS: We identified 225,584 TKAs (208,954 primaries, 16,630 revisions) in the 2003-2012 Statewide Planning and Research Cooperative System database. Odds ratios (ORs) expressed the risk of VTED for revision vs primary TKA, and models were adjusted for age, gender, race, and Charlson comorbidity scores. Outcome analyses were further stratified into deep venous thromboses (DVTs) and pulmonary emboli (PEs). RESULTS: The incidence of VTED within 30 days was 2.24% for primary and 1.84% for revision. In multivariable-adjusted regression, the OR of VTED within 30 days for revision compared with primary was 0.81 (95% confidence interval = 0.72-0.91; P < .001). The incidence of VTED within 90 days was 2.42% for primary and 2.13% for revision (P = .022), with a multivariable-adjusted OR of 0.87 (95% confidence interval = 0.78-0.97; P = .010) for revision compared with primary. The association was stronger for PE (OR = 0.63; P < .001) than DVT (OR = 0.87; P = .035) at 30 days, and significant for PE (OR = 0.69; P < .001), but not DVT (OR = 0.94; P = .284) at 90 days. CONCLUSION: In a large statewide database, the risk of VTED was lower for revision TKA compared with primary TKA. The reasons for this observation are not known, but might be related to aggressive prophylactic management of patients undergoing revision procedures. Future studies should attempt to clarify differences in patient selection and management for primary vs revision procedures.
引用
- Boylan MR, Perfetti DC, Kapadia BH, et al. Venous Thromboembolic Disease in Revision vs Primary Total Knee Arthroplasty. J Arthroplasty. 2017. PMID: 28209273. doi:10.1016/j.arth.2016.12.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。